Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H23NO4 |
| Molecular Weight | 293.3581 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(OC1=CC=CC=C1)C(=O)OCCN2CCOCC2
InChI
InChIKey=GMISKEUWHIRDNK-UHFFFAOYSA-N
InChI=1S/C16H23NO4/c1-16(2,21-14-6-4-3-5-7-14)15(18)20-13-10-17-8-11-19-12-9-17/h3-7H,8-13H2,1-2H3
Promolate is an Isobutyric acid derivative with potent antitussive activity. In preclinical studies, Promolate shows low toxicity in experimental animals and an antitussive action like that of codeine, but without the side effects of the latter. Promolate displayed a dose-dependent antitussive effect in conscious guinea pigs with coughing induced by NH3 aerosol. The activity of Promolate did not diminish when it was administered orally to guinea pigs for 20 days. Promolate also displayed a dose-dependent antitussive effect in Na barbital anesthetized cats with coughing induced by stimulation of the superior laryngeal nerve. High doses of Promolate administered to rats for 125 days did not provoke side effects.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4242953
guinea pig: 400-1400 mg/kg orally or rectally
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29698
Created by
admin on Mon Mar 31 18:32:19 GMT 2025 , Edited by admin on Mon Mar 31 18:32:19 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2106992
Created by
admin on Mon Mar 31 18:32:19 GMT 2025 , Edited by admin on Mon Mar 31 18:32:19 GMT 2025
|
PRIMARY | |||
|
C73178
Created by
admin on Mon Mar 31 18:32:19 GMT 2025 , Edited by admin on Mon Mar 31 18:32:19 GMT 2025
|
PRIMARY | |||
|
222-797-6
Created by
admin on Mon Mar 31 18:32:19 GMT 2025 , Edited by admin on Mon Mar 31 18:32:19 GMT 2025
|
PRIMARY | |||
|
SUB10090MIG
Created by
admin on Mon Mar 31 18:32:19 GMT 2025 , Edited by admin on Mon Mar 31 18:32:19 GMT 2025
|
PRIMARY | |||
|
5WGM277OKR
Created by
admin on Mon Mar 31 18:32:19 GMT 2025 , Edited by admin on Mon Mar 31 18:32:19 GMT 2025
|
PRIMARY | |||
|
DTXSID80189721
Created by
admin on Mon Mar 31 18:32:19 GMT 2025 , Edited by admin on Mon Mar 31 18:32:19 GMT 2025
|
PRIMARY | |||
|
2607
Created by
admin on Mon Mar 31 18:32:19 GMT 2025 , Edited by admin on Mon Mar 31 18:32:19 GMT 2025
|
PRIMARY | |||
|
C022055
Created by
admin on Mon Mar 31 18:32:19 GMT 2025 , Edited by admin on Mon Mar 31 18:32:19 GMT 2025
|
PRIMARY | |||
|
3615-74-5
Created by
admin on Mon Mar 31 18:32:19 GMT 2025 , Edited by admin on Mon Mar 31 18:32:19 GMT 2025
|
PRIMARY | |||
|
71133
Created by
admin on Mon Mar 31 18:32:19 GMT 2025 , Edited by admin on Mon Mar 31 18:32:19 GMT 2025
|
PRIMARY | |||
|
100000081147
Created by
admin on Mon Mar 31 18:32:19 GMT 2025 , Edited by admin on Mon Mar 31 18:32:19 GMT 2025
|
PRIMARY |
ACTIVE MOIETY